Last reviewed · How we verify
Osteomyelitis due to Staphylococcus aureus
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Cefaprin · Bristol-Myers Squibb
- Nallpen In Plastic Container · Pfizer
- Cleocin T · Pfizer
Cleocin T works by inhibiting protein synthesis in bacteria, preventing them from producing essential proteins and ultimately leading to cell death. - Tobi · Novartis
- Vancocin · ANI Pharmaceuticals
- Nallpen In Plastic Container · Pfizer
- Cleocin · Generic (originally Upjohn/Pfizer)
Lincosamide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with excellent anaerobic coverage. - Vantobra · Pfizer
- Cefadole
Cefadole works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Nebcin · University Hospital, Lille
- Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Mefoxin In Sodium Chloride 0.9% In Plastic Container
- Monocid
- Cefotan
- Keflex · Shionogi
- TICARCILLIN
- Ticarcillin
- Zinacef · GSK
Zinacef works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Augmentin 250 · Dr Reddys Labs Inc
- Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Epocelin
- Bactocill In Plastic Container · Apothecon
- Ceftazidim · Tel-Aviv Sourasky Medical Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Osteomyelitis due to Staphylococcus aureus patent landscape — cliff calendar, originator estates, attackable patents
- Osteomyelitis due to Staphylococcus aureus treatment landscape brief
- Osteomyelitis due to Staphylococcus aureus treatment updates RSS
Frequently asked questions about Osteomyelitis due to Staphylococcus aureus
What drugs treat Osteomyelitis due to Staphylococcus aureus?
Tracked treatments include Ramycin, Cefaprin, Nallpen In Plastic Container, Cleocin T, Tobi, Vancocin, Cleocin, Vantobra.
What is the treatment for Osteomyelitis due to Staphylococcus aureus?
Standard treatment for Osteomyelitis due to Staphylococcus aureus includes Ramycin, Cefaprin, Nallpen In Plastic Container, Cleocin T, Tobi. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Osteomyelitis due to Staphylococcus aureus patent cliff · Osteomyelitis due to Staphylococcus aureus CI report
- Treatment: Ramycin
- Treatment: Cefaprin · Bristol-Myers Squibb
- Treatment: Nallpen In Plastic Container · Pfizer
- Treatment: Cleocin T · Pfizer
- Treatment: Tobi · Novartis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing